Targeting Protein Degradation 4
October 15-16, 2024, Cranfield University, UK. Vipergen will present a poster entitled: DELs in Cells – Direct Screening for Molecular Glue
Targeting Protein Degradation 4 Read More »
News
DELs in Cells – Snap
Your easy, fast and affordable way to get an early lead Never been easier Low cost Standardized process No need for purified target protein. Screening under physiologically relevant conditions High success rate Hit exclusivity for 25 top hits You provide your target amino acid sequence, and we provide DEL screening inside a living cell in
DELs in Cells – Snap Read More »
Discovery on Target 2024
Boston, US, September 30 – October 3, 2024 Vipergen presents a poster entitled: DELs in Cells: Direct Screening of DNA encoded Libraries for PPI Inhibitors. https://www.discoveryontarget.com
Discovery on Target 2024 Read More »
EFMC-ISMC 2024 – XXVIII EFMC International Symposium on Medicinal Chemistry
September 1-3, 2024, Rome, Italy Vipergen will show a poster entitled: Generation of High-quality and Diverse DNA-encoded Libraries Link to event
EFMC-ISMC 2024 – XXVIII EFMC International Symposium on Medicinal Chemistry Read More »
RICT 2024 – 58th International Conference on Medicinal Chemistry
July 3-5, Bordeaux, France Vipergen will show a poster entitled: High Fidelity DNA-encoded Libraries Link to event
RICT 2024 – 58th International Conference on Medicinal Chemistry Read More »
38th ACS National Medicinal Chemistry Symposium
June 23-26, Seattle, US Vipergen will show a poster and give a flash presentation entitled: DELs in Cells – Direct screening for Molecular Glue Link to event
38th ACS National Medicinal Chemistry Symposium Read More »
SLAS Europe 2024
May 27-29, Barcelona, Spain Vipergen will show a poster entitled: Multiplex Screening of DNA-Encoded Small Molecule Libraries inside a Living Cell Link to event
Discovery Europe 2024
May 22-23, Basel, Switzerland Vipergen will give a talk entitled: Molecular Glue, DELs and Protein Degradation Link to event
Discovery Europe 2024 Read More »
Aurigene Pharmaceutical Services Ltd., and Vipergen announce a strategic partnership for offering DNA encoded library (DEL) screening and integrated drug discovery services.
Hyderabad, India, and Copenhagen, Denmark; April 19, 2024: Aurigene Pharmaceutical Services Ltd. (Aurigene), a global contract research, development, and manufacturing services organization (CRDMO), and Vipergen ApS, a niche small-molecule drug discovery service provider specialized in DEL technologies, entered into a strategic partnership. The collaboration aims to co-market and offer DEL screening technologies to global customers
The Morten Meldahl Symposium 2024
Copenhagen, DK, April 15-16, 2024 Vipergen will present a poster entitled DELs in Cells – Direct Screening for Molecular Glues Link to conference site: https://eventsignup.ku.dk/mortenmeldalsymposium2024
The Morten Meldahl Symposium 2024 Read More »